FLUZONE HIGH-DOSE QUADRIVALENT DIN 02500523
Status: Dormant
Holder: SANOFI VACCINES CANADA LTD.
Molecule: HAEMAGGLUTININ-STRAIN A (H1N1)
Available to quote
Health Canada record
| Active ingredient(s) | HAEMAGGLUTININ-STRAIN A (H1N1) 60 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 60 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 60 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 60 MCG |
|---|---|
| Dosage form | Suspension |
| Route | Intramuscular |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
| Original market date | 17-Sep-2021 |
| Current status date | 12-Feb-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanofi Vaccines Canada Ltd. — licence 101420, currently licensed, last inspection rating C (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing HAEMAGGLUTININ-STRAIN A (H1N1)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02362384 | FLUAD | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02553716 | FLUCELVAX | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Approved |
| 02553708 | FLUCELVAX | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02494256 | FLUCELVAX QUAD | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Approved |
| 02478978 | FLULAVAL TETRA | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Approved |
| 02567695 | FLUVIRAL | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Approved |
| 02420686 | FLUVIRAL | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02365936 | FLUZONE | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02365707 | FLUZONE | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02269562 | INFLUVAC | BGP PHARMA ULC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Marketed |
| 02484854 | INFLUVAC TETRA | BGP PHARMA ULC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Marketed |
| 02542714 | PANENZA | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG | Approved |
| 02473283 | AFLURIA TETRA | SEQIRUS PTY LTD | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Cancelled Post Market |
| 02473313 | AFLURIA TETRA | SEQIRUS PTY LTD | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Cancelled Post Market |
| 02428881 | AGRIFLU | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Pre Market |
| 02346850 | AGRIFLU | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Pre Market |
| 02434881 | FLUAD PEDIATRIC | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 7.5 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 7.5 MCG; HAEMAGGLUTININ-STRAIN B 7.5 MCG | Dormant |
| 02494248 | FLUCELVAX QUAD | SEQIRUS UK LIMITED | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Dormant |
| 02420783 | FLULAVAL TETRA | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Dormant |
| 02015986 | FLUVIRAL | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Post Market |
| 01914510 | FLUVIRAL | ID BIOMEDICAL CORPORATION OF QUEBEC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Post Market |
| 02365715 | FLUZONE | SANOFI PASTEUR INC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Pre Market |
| 02365693 | FLUZONE | SANOFI PASTEUR INC | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 7.5 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 7.5 MCG; HAEMAGGLUTININ-STRAIN B 7.5 MCG | Cancelled Pre Market |
| 02432730 | FLUZONE QUADRIVALENT | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 30 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 30 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 30 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 30 MCG | Dormant |
| 02420651 | FLUZONE QUADRIVALENT | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 15 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 15 MCG | Cancelled Pre Market |
| 02420635 | FLUZONE QUADRIVALENT | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 7.5 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 7.5 MCG; HAEMAGGLUTININ-STRAIN B (VICTORIA) 7.5 MCG; HAEMAGGLUTININ-STRAIN B (YAMAGATA) 7.5 MCG | Cancelled Pre Market |
| 02348764 | INTANZA | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Post Market |
| 02348756 | INTANZA | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 9 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 9 MCG; HAEMAGGLUTININ-STRAIN B 9 MCG | Cancelled Post Market |
| 02367718 | VAXIGRIP | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Post Market |
| 02223929 | VAXIGRIP | SANOFI VACCINES CANADA LTD. | Suspension | HAEMAGGLUTININ-STRAIN A (H1N1) 15 MCG; HAEMAGGLUTININ-STRAIN A (H3N2) 15 MCG; HAEMAGGLUTININ-STRAIN B 15 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23800 | 2020-06-16 | Supplement to a New Drug Submission (SNDS) | indication for: FLUZONE® High-Dose Quadrivalent vaccine is indicated for active immunization against influenza caused by the specific strains of influenza virus contained in the vaccine in adults 65 years of age and older. |